It was with great joy and happiness today, that I read Circadian’s (ASX : CIR) AGM agenda.
This is a big deal. Finally, the company has decided to change its name and re-identify itself as the inner person it always needed to be : Opthea. It’s not a perfect brand, mind-you. When I think of Opthea, this is what I come up with:
… but well done. It’s a start.
If shareholders really want to do well by the company, they should not only approve the new name – but they should also decide that after 10 years, it’s time for Dominique Fisher to step down. Here is recap, in case you have forgotten:
No public company should have a non-executive director for 10 years. What CIR needs most right now is a board that can:
- Build partnering relationships for the company’s opthamology technology and redefine the business as a leading eye-care company (sans Circadian baggage).
- Carefully monitor and govern a fairly complex biologics development program and clinical trial(s).
- Mentor and develop a high-potential CEO.
Dominique should retire.
Thank you Diana for the feature image.